Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NQDI-1

Copy Product Info
😃Good
Catalog No. T3101Cas No. 175026-96-7
Alias NQDI1, NQDI 1

NQDI-1 (NQDI 1) is a selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1, MAP3K5) (IC50/Ki: 3 μM/500 nM).

NQDI-1

NQDI-1

Copy Product Info
😃Good
Purity: 98.80%
Catalog No. T3101Alias NQDI1, NQDI 1Cas No. 175026-96-7
NQDI-1 (NQDI 1) is a selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1, MAP3K5) (IC50/Ki: 3 μM/500 nM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$40In StockIn Stock
10 mg$67In StockIn Stock
25 mg$147In StockIn Stock
50 mg$273In StockIn Stock
100 mg$413-In Stock
200 mg$589-In Stock
500 mg$939-In Stock
1 mL x 10 mM (in DMSO)$44In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.80%
Appearance:Solid
Contact us for more batch information

Resource Download

Product Introduction

NQDI-1 AI Summary
NQDI-1 demonstrates diverse bioactivities across multiple targets, suggesting its potential as a multi-target therapeutic agent. It exhibits potency in modulating lipid storage, inhibiting histone lysine methyltransferase G9a, delaying death in the malarial parasite plastid, inhibiting Polymerase Iota and Eta, acting as an inverse agonist of the GLP-1 receptor, and inhibiting Pin1. Furthermore, it competitively inhibits human ASK1 with a Ki value of 500 nM and an IC50 value of 3000 nM, and completely inhibits ROCK1 and JNK3 activity at 25 µM after 20 minutes. The compound also shows varying degrees of inhibition against Aurora A, HGFR, FGFR1, Tie2, and CK2. Additionally, NQDI-1 exhibits antiviral activity by inhibiting SARS-CoV-2 induced cytotoxicity in Caco-2 and VERO-6 cells and SARS-CoV-2 3CL-Pro protease by 13.05% at 20 µM. The compound also demonstrates inhibition of human HDAC6 enzyme activity with 41.78% inhibition using a standard peptide substrate. These multifaceted pharmacological effects make NQDI-1 a candidate for further drug development exploration..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
NQDI-1 (NQDI 1) is a selective inhibitor of apoptosis signal-regulating kinase 1 (ASK1, MAP3K5) (IC50/Ki: 3 μM/500 nM).
Targets&IC50
ASK1:500 nM (Ki), ASK1:3 μM, MAP3K5:3 μM
SynonymsNQDI1, NQDI 1
Chemical Properties
Molecular Weight319.31
FormulaC19H13NO4
Cas No.175026-96-7
SmilesCCOC(=O)c1c2-c3ccccc3C(=O)c3cccc([nH]c1=O)c23
Relative Density.1.42 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 3.2 mg/mL (10.02 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1318 mL15.6588 mL31.3175 mL156.5876 mL
5 mM0.6264 mL3.1318 mL6.2635 mL31.3175 mL
10 mM0.3132 mL1.5659 mL3.1318 mL15.6588 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy NQDI-1 | purchase NQDI-1 | NQDI-1 cost | order NQDI-1 | NQDI-1 chemical structure | NQDI-1 formula | NQDI-1 molecular weight